FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup.
D002675:Child, Preschool; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D010372:Pediatrics; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000008:administration & dosage* / Q000627:therapeutic use
D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine